Microhematuria assessment an IBCN consensus—Based upon a critical review of current guidelines
详细信息 查看全文
- 作者：Bernd J. Schmitz-Drä ; ger ; M.D. ; Ph.D.a ; b ; bernd_sd@yahoo.de" class="auth_mail" title="E-mail the corresponding author ; Eva C. Kuckuck ; M.D.a ; Tahlita C.M. Zuiverloon ; M.D.c ; Ellen C. Zwarthoff ; Ph.D.d ; Amanda Saltzman ; M.D.e ; Abhishek Srivastava ; M.D.f ; M&rsquo ; Liss A. Hudson ; M.D.g ; Roland Seiler ; M.D.h ; i ; Tilmann Todenhö ; fer ; M.D.i ; j ; Antonia Vlahou ; Ph.D.k ; H. Barton Grossman ; M.D.l ; Mark P. Schoenberg ; M.D.f ; Marta Sanchez-Carbayo ; Ph.D.m ; Lenuta-A. Brü ; nn ; M.D.n ; Bas W.G. van Rhijn ; M.D.o ; Peter J. Goebell ; M.D.b ; Ashish M. Kamat ; M.D.l ; Morgan Roupret ; M.D.p ; Sharokh F. Shariat ; M.D.q ; Lambertus A. Kiemeney ; Ph.D.c
- 关键词：Microhematuria ; Urine markers ; Bladder cancer ; Urine cytology ; Diagnosis ; Disease management ; Guidelines
- 刊名：Urologic Oncology: Seminars and Original Investigations
- 出版年：2016
- 出版时间：October 2016
- 年：2016
- 卷：34
- 期：10
- 页码：437-451
- 全文大小：453 K
文摘
- •
Assessment of patients with asymptomatic microhematuria (aMh) remaines a challenge to urologists.
- •
Current clinical guidelines differ in a variety of parameters.
- •
Most guidelines appear complicated and are not practical for routine use.
- •
New concepts for risk assessment permitting improved risk stratification are needed.